International Conference on

(1)

(2)

PROCEEDING

“The 2

^nd

International Conference on

Pharmacy and Advanced Pharmaceutical Sciences”

Book II : Clinical and Social Pharmacy First edition, November 2011

Project Editor: Triana Hertiani

Designers: Puma Arfah and Firman Romansjah

Published by:

Faculty of Pharmacy Universitas Gadjah Mada Sekip Utara, Yogyakarta, 55281,

Indonesia

Editor : Ronny Martien

: Zullies Ikawati Editor in Chief : Triana Hertiani

ISBN : 978-979-95555-9-5

No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, mechanical, photocopying, reccording or otherwise, without the prior permission of the copyright owner

Printed by:

PASS OFFSET Jl. Lowanu 23

Yogyakarta - Indonesia

(3)

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences i Preface from the Editor

! " # " $ % & $ $

% $

% & ' ( ) * + &

, % - - .)

/0 $ % & 1 23 & 2

( ) * + $ 2

& 4 & &

& 2" $ 5

' &

& 6 ( ) * + ,

% # - - .) /0

& 7 7 5 &

$ 7 & 0

5 ' &

$

7 &

$

# "

- $ $ $ % 8 +$ $ $

(4)

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences ii

Organizing Commitee

Steering Committee

$ - $ + -/ $ $ 9 ()+ :

$ - $ ; +$ $ $ 9 ()+ :

$ - $ / + +$ $ $ 9 ()+ :

- $ < , +$ $ $ 9 ()+ :

$ - $ -* ; $ 9 ()+ :

$ - $ = & $ 9 ()+ :

$ - $ 9% :

$ + < & $ -$ 9, % # : Chairman

- $ $ $ % 8 +$ $ $

Secretary

- $ $ $ 6 + +$ $

- $ $ $ 6 $ / > +$ $ $

Treasure

$+

(5)

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences iii Welcome to Yogyakarta,

- > )

5 5 ' &

" $

% ' ( ) * + & ,

% - - .)

/0 $ % 1 23 & 2

( ) * + $ ?

& 4 & &

& 2" $ 8 & &

& 0 *

& 0 $

% 5 ' & 6 ( ) * + ,

% # - - .) /0

. & 7 7 5 &

$ 7 & 0

5 ' & $

7 & *

(6)

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences iv

Remarks of the Dean of Faculty

@ & $ & $

- A $

7 7 ( ) * + & &

$ & $

>

% ' 7 ()+ & ,

% 9, %: # - - ) 23

7 ()+ 2 ( ) * + $ &

B $

& $

& & * &

$ & 0

$

% & & &

& & & *

$

7 & &

$

&

Wassalamu’alaikum warahmatullahi wabarakatuh, +

- 7 ()+

(7)

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences v Opening Remarks by Rector of Universitas Gadjah Mada

$ $ * & +$ / $ $ - C

1 & &

C $ - $ /

-

) $ 1 & %

& DC

E ' & - - ,

% # 23 7 ()+$ %

$ 0

&

& $ %

F 1 &

$ +

&

& & $

& & & &

$ & &

& & & &

$ & &

$ & * & # * $ >

& $

% $

; 1 & & $

(8)

! " #

$ !

% & "

% ' ( ! ) ' *

+ ' ) ' ! " )

, ' - ' ) ' ! (

! ' !. , ' . * / ' 0 ( '

( * ' ! ( ' # ( ,

( ' % + '

! !

' ' 1 )

"

' ' 1 )

% + ' ( '

* ' 1 ' & " ' 0

2 3 2

4 5 6

7 5 48

44 5 47

49 5 4:

;8 5 ;7

;9 5 <=

<6 5 <9

<> 5 ==

(9)

" !. * ( ' * . & ' . " ' * ' ? . + "

!

' ! ' ' 0 "

#

$ %

! !

0 * ' @ + (' @ + A ' , B' ! ' , + '% -

"

&

. ( *' * 3 ' "

"

' ) ' ' ' *

# '

, '

! ! !

,. ' A @.+' .!.' + .,.' . .' + .,.' - %

"

' ) ' ' ' *

1 ) ' " ! ( ' 0 ' ,

$ , . ' . 3% .' & ' '

! " ' + ' " " ('

(

! " ' #) " ' # (

# ) &

"' #) " ' # (

" * !

! $ %

# " ( ' ( #( & ' @ 3 /

=6 5 6;

6< 5 6:

785 79

7> 5 9;

9< 5 97

99 5 >;

>< 5 >:

:8 5 :=

:6 5 48<

48= 5 489

48> 5 44;

44< 5 446

4475 4;9

4;> 5 4<6

(10)

. . ( *' , ' ( ' 0

2 )

$ % +

! '

& (,-,

! ' # ( ' # " % ( '

% , !# 1 * !

% , !# # C

# 1

4<7 3 4<:

4=8 3 47;

47< 3 49=

496 499 49>

(11)

Nyoman Kertia et al.

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Science ix

! "

# $ %&'(

) * + !

&' # +

$ )

+ ) ) +

* $ '

, + *+ ) -. ) $

+ / / % (

-.. - 0 1 % ( )

) + ) ) &' ! ) )

2

! * 3 ) 4 *

) , + # ) , #

* ) ) *

' 56 ) &' ) # )

$ ) 2 78 856 96 ) ) ! 2 7: 78- 5-

1 + # '

$ ) . 68 * $ ) 2

78 856 96; . 68 < 2 -9/ 7:: 5: # ' +

1 ) . =7 *

) 2 7: 78- 5-; . =7 < 2 5- 97. =/ *

6 ) ! ) 2 5 5.6 ./ ) + *

+ 1 #

&' ) ) ! + / / -.. -

1 ) ) + * -. )

$

; 0 * > 4 $ > 0 + 0 1

> &

!" #

& %&'( ) , +

)

+ ) , $

(12)

Cost-Effectiveness Between...

x ^{The 2}^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Science

& 3 +

+ ? $

# &' + +

-

4 $ * * %@ ' (

# 0&A

+ 1 + + $ ^{6 :} #

@ ' !

@ ' ⁷ :. ) &' ) $

9 ) 5.B

$ ) +

+ ) '

$ :. ) :-*8. ⁵ 0 %

( + + +

' + + $

% * $ ( $ $ ⁸

C $ &'

) # $

+ + #

* +

1 $ &'

$% !#

&" '$ %

+ ) ) ! &' )

2 !

! &'> ) $ &' + D 3

%E /( & ) + ' 0 2

) ) C$

&' >

+ + ) F 6 G $

@ '

$&$ $% !#

# ) , + *+ ' + )

$ $

) + &'

&' $

+ * - % (

) ! 0 &' $ %D 3 $(

3 ) &' ) + '

%' (⁹

+ ) ) 4

! ) & 4 $ %

-. $ ( % / /

(13)

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Science xi

-.. - 1 ( ' ) ) !

+ ) # ) ! ) * )

+ + + $ # )

) ) ! ) + #

+ + C 0 H 2

+

&% %(&%( ) )*&(&

# $

+ 1 ) ,

+ ) , + * 3 4 *

) , + D ) E. .5

) /5B # ) ,

# * ) ) *

$&")%

) &' ) #) $ +

= + + + +

+ + $

+ 6 ! @ ' $ - + !

- + ) + ) - + )

# + ) 79 ) 6- 68 )

87 59 I 9 9: % ) :9 ) =6 (

) -. := I : /: &' ) 5- 7: I

76 -: + ) ! &' ) := + ! &' ) 8

+ &' : + D 3 $ ) 5 65 I 6 75

79 + := + ) 5 + )

7 + ) !

4 $ ) + % E . .-( ) +

1 ) + %

<. .6( ) % E . .-(

+ $ ) -

! ) + 1 0

+ $ +

+ - +

# ) $ ) 2 78 856 96 ) ) !

1 2 7: 78- 5- #

' $ ) . 68 * $ ) 2

78 856 96 ; . 68 < 2 -9/ 7:: 5: # '

+ 1 ) . =7 *

) 2 7: 78- 5-; . =7 < 2 5- 97. =/ *

+ 1

$ 6 ) ! ) 5 5.6 ./ ) + +

1

(14)

xii ^{The 2}^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Science

#(& "&&(!

# ) , + *+ )

0 + * + +

' &' %-: 5B

-.B ( + 6/ -B + 6: 5B

=

# ) *

+ ) )

*

/ + *

0 +

! * * ) / 8B )

$ * %6.B(

# + + 1

) + $ H

) ) + '

* )

* $ * $ ^-. *

+ >

! * +

&'^-- )

) $ ) + &' +

+ &' 0

+

) ) ) ^-6 H 0 *

4 % ( $ 6.B 7.B

7.B @ ' #

+ -... $ % ) 6.. (

' = &' + / : #

#

* &'^-:

2 )

+ $

) &' ^-7 )

) + +

+

1 $ '

$ ! @

+ ) ! + + )

) ! +

+ ) !

(15)

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Science xiii

# ) 4 -

-. $ ) 2 :-9 =5 # / /

-.. - ) 2 7-= .. # )

) %- + : : ( %- + 6

: ( 4 - + ) 2 :8 .. - +

) 2 -:: 5. # ) ) +

+ $ $ ) 2

6 5.. .. D + $ 2 -8 7.. ..

)

3 + ' 3

) &' ) ' 3 # *

. 86 . /7 %/-B . 85( )

* ) . 8: . /6 %=6B . 85(

2 + ) ) ) % ( +

! *

! ) )

2 0 ) )

D ! ) + )

+ :.

! )"&(!

+

+ 1 )

) $ # )

+ ) ! + ) $ +

1 0 *

&' + + / /

-.. - 1 ) ) 2 5- 97. /= # ) +

-. $ ) ) ) ! ) ) 2 -9/ 7:: 5: )

* 2 5 5.6 ./

&" $&%(!

+ 1 + *

$ +

1 )

'

$+$ $ $&

$ H ' 6..9

6%7( 5//*8.7

4 H + 0 6..5 0&A*6 + * D :56;--*

-9

(16)

xiv ^{The 2}^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Science

H D D D , J 4 ! K D 6..8

-- ) @ ) !

D 6..= & ; # K J J 0 D J L 4

% ( ! " # -: 6:5*7. ' @ )

!

# -//5 @ ) 4 ' * 4 % (

$# -*-6 ' !

J H M ! D ! H 2 6..7 H 4 0 0

' ! % & 77;/9*---

' ' -//7 C! K H 4 ! D 2 4

' ( ' ( "& % ( ( (

)* +!&) " & , ! -5.*-57

K D ! 2 # 0 # ! ' K ) -//8

! 2 ! ! & - (

. H )

D ) J 2 D) K -//. / $ & & 0 &

J L N @ ) !

! J D & , J @ J H 0 D , 2 0 J O '

# H @ 6..8 # C$ 0 0 4 C$

2 ' 8/%:(; :5-"55

' 2 # M ' -//5 $

2 ' 7%' ! ( 0 &$

$ !

0 @ 6..: ' * ' 0 ; ' 0

# % ( /%-(;-8-*8=

H 0 2 4 D D ' #

' 6.-. C 0 * 0 $

C$ ' & 4 ! 1 6- 6.-.

; -5 7

2 4 ' ' K @ -//8 K ! H ' 4 4 ! !

+ ! K + K ! ! ' K ! 4

& %4 4 ( ' ( $ (

" 2 4

(17)

Amelia Lorensia et al.

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Science 1

!

"#$ %& ' ( ) ! %*

! +,- ! %.

- !

!

! /

!

(, 0 !1 2

3 - 4 !1

! /

!

! 5. -

6&7 !

! 89 65* ( ! ! ! :6 ! -

! 79 .;*

% 7<* - !1 !

!

! / !1

= !1

!"

# ! !

1 ! !

$ >

! ^% ! "#$ 0"

# $ ! / 2 %& ' 1 0( ) 2

! %* ! ^# +,- 0

+ , - !! 2 ! %.

%795 +,- ?$ ( 0

2 4 & %. +,-@ %776

?$ ( 8 ! 0 2 " %77&

%<A%... ! %%A%... 6A%... ^& -

B C ! 0B C 2

(18)

Study of drug-selection……….

2 ^{The 2}^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Science / !

! ! ^#

! 4 ^&

- !

!

! /

C 4

- ! # !

/ ! ! %.. 0

! 05.2 ! 08.22

1

'

-

! ' ! !1

! ⁽ -

! ! 0 !

A (, 2 ⁾(,

: 06..;2 ' (,

, (, 06<*2

' ! 0%%*2

0;*2 ! ! '

(, 0D8.*2 ⁾ !

(, ^*

3 -

!1

0(, 2 ⁺ ! !

#, ## !1

( !1

! $ / ! !1

! ! 3

#$

- 4 !1

/

- . /0

-

1 2 3 1 3 4 5

( ! = !1

=

!

(19)

6 7 1 7

- / # "

# B 6..9 B 6.%. /

! # " # B 6..9 B

6.%.

1 3 31

!

8! 8"!88

5. - 66

0<5 5;*2 <9 05< <<*2 !

! 6. ' ! 96 $ 5.

8& 88* %%16. E 66 ;<* 6. E 66 ;<*

61& 8 &&* 51%. 8 && *

/ !

! !

4 !

# #%

5 #9 1 7 2 :8 31 6 5 8 7 1 " 3 1

:8 31 6 5 7 3 0*2

!

0 1 2

%6& . %6& 89 65

B ! 9 . 9 < .7

! !

& &8 &7 66 ;9

!

6& . 6& 7 5&

!1 6 . 6 . ;;

- ! 6 . 6 . ;;

F 1 ! < . < % %5

! A !

3 !

%; . %; 5 &5

B ! %9 . %9 5 7&

$,' '& $'+

(20)

Study of drug-selection……….

4 ^{The 2}^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Science

( ! ! ! !1 ' -

- A

! " 4 :6

! - A

!1 ^#

- !

=

% ! 0 2

> > 06..72

6 + C 1 =

? !

, ! / ! ! !

, ! / G

, ! / ! !!

B

" " !8 -

! ! 0

F, A F , 2 F ! !

/ !1 A A '

4 !

; "

> > ! F ! H 0 2

6..7

/ F I F ! F JF F + + 1 4 C

: ! +? =

J ? 6..%E 8%= 5591;5

B C ! > !

! = C' , 6 B # = B

# ! : %77;

F ! # " + ( )

( ! 4 = ( 4

6..8

C > C # 1:

? 6..9 J 1F E50%2=6&1<6

: ! : ? ? F FJ F 1? FJ ? =

? 6..8 ( 8E%.0<%2=<7<%185

+: /1 : =

6..&E<7=&<718%

(21)

: ( ! , F F ? "

# $ ! / = C F ( 0C(F2=

? ! F 0 ? F2 K L 6..; K 6.%. J

6%L

# 1 # > / F

? J # 1 %775E&<= %;%<M5

? , + " + 1+ F ) ! ) > ! :J ! :+

- ? = + 1+ F ) ! ) + "

> ! :J ? , - = - ? ( ! 9

" H " 4 E 6..&=% %1% 6%

F I ( !1 = ? ? J F

? ! K L 6..&E%.

, = =AA !A A A%.16 4 %8 $4 6..;

: ' # I 4 + , - F : # - F #

# ( !1, = , > #

C J ? ! K L 6..8 K 6.%. ( %8LE5.072

, = =AA ! 4 A A !! 3'.; 6' 'A

F ! # 4 B ? E 6..5

(22)

Ana Yuda et al.

!

"# $%

# &

'

( ) *+,,

-+ -+

$ .+ "*. ,/%

# $

0 .+ "1 */%

*+/ ",12.+%

34 5 3/ ( 1* 6/

,* 3/ *+

7 7

&

!"

89 &

") : *++6% ; <90 "*+,,% *++4 ! 1*3 1*3

89 ) : "*++6%

) 9 89 #

# # !

89 "8 = *++6% #

0

"# $%

(23)

The profile of community pharmacies...

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Science 7 0

"8 ,---% :

# "# $%

# $ % &

& '

( )

*+,, -+

>

- - - -

#

# *+

" * ,%

>

, (

* 5

1 " %

3

4 # 7 & 7

&

. # 7 & 7 ? ?

? ?

6 7

" %

(24)

Ana Yuda et al.

8 ^{The 2}^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Science 34

' 2

# ) @

A! 7

2 * 7

7 2 B

$ 9

0 @

2

@

A "C

D ) 7 % #

# A E 8 "#7 7 # %

'!% ' '"!'' '

-+ # ( *+

"** */% # C $

A

89 # &

*+ "56 3/%

7 &

!

7

# "0 8% &

#

" A DA '# *++4%

0 .+ "1 */%

'

!

*+/ ",12.+% 34 5 3/ (

1* 6/ ,* 3/ ;

) 9 # $ ,+*. *++1

C

(25)

The profile of community pharmacies...

*, 7

7

( !

( ) ( *

$ $ & /

, -+ *+ ** *

* 7 .+ *+ *6 3

5 F .+ 5 1 *

1 F .+ , , 1

3 C >

<

< (

.+

34 34 34

,1

*1 .

*

*+ + 1* 6 ,* 3 5 3

. >

<

< (

.+

*,

*, 5 4

* , 1

5+ + ,1 *

*6 3 - 3 1 . ,- +

" "%!'

&

" % & #

: F

+ " '

7 *++4 B ' # > )

A "A % # , ' - E 7 > C 7

A7 ,**@,14

8 *++6 # 9 > 8 @; ) < ; F

C ) ) D E ) ' E 8 E "A %

(26)

Ana Yuda et al.

, . ( , . ( / , . . > ) F @9 8 #

,+,

8 ) ' ,--- ) A ' > 8 ) ' "A %

# . >

D ' 7 # *++1 ( 0

12345# '5' 5 653227 ) ' , * ( 0

E 7 > D ' 7 #

D ' 7 # *++4 , , )) 8 9 8

9 8 8 E 7 7 ; D 7 : ; D

D D ' 7 #

D ' 7 # *++- , * 322: E 7 >

D ' 7 #

A 9 ,--4 > C E "A % ) ! " . " ' *

, . * C > *3@13

9 ) 8 ) *++4 B

9 B > ) A "A % #

, ' - E 7 > C 7 A7

16@4-

C D C ,--. ' ( ' ; $ '

, . . # F > <90

< ) 8 7 E ' ; 8 ) 8 < 7 8 ) F E ) ) E

*++1 8 , '.

$ > D *4 5*@5.

< ) 8 $ F F *++4 '

' < * , .

, . . ,1 65@-5

(27)

Anita Purnamayanti Rahman et al.

!

! " !!

# !

$ !

" !! % & '

$ % $ $ ( ( " ) '

*

+ ,

( - * ! ,

!

! ( - '

* * .

( - . / 0 .

( 0

+ 1 (! 0

! 2( ! 0 0

( - 3 * . 4

!

5 6 7 7

& ! 1899:2( - 0 *

* ! ! , ( -

0 , 0 ( )

. ; 4

5 ( -

! (

" 4 0

# $ %!&'$#%

- !

! + ! (

! , !

! (

(28)

Pharmacoeconomics study as a...

< 1 2 *

(⁸

- ' 0 0

0 , (^{8 = >}

- 8( - (⁼

- +

! ( $

1 !( ! 2( $

1 !(

2 ^{8 >}

! 1 !

2( ! ! 5

< (⁸

" ' !

! * ! ( $ !

'

( - > ?@

! (⁼

! ! (

- A * ! ⁸

# ! (

! !

( ($ %!%)%

- * ! ,

! !

( - ' * *

. ( -

(29)

. / 0 .

(

- 3 * . 4

!

5 6 7 7 &

! 1899:2(⁸ - 0 *

* ! ! , ( - 0

, 0 ( *

, ! (

(*&)$* ! !#*'&**#% *

) . ; 4

5 (

) 6

!( . * *

> '

(

* (

!

! (⁸- .

- =( - % % *

- 8 - =

#

B < 5 * C

$ + 5

! C

D D

+ ,

B * C 1

! 2

D D

(-- ,

B 5 ! *

* C

- ! , *

! C

D

E

D

E

- 8 - =

. ,

$

C

D D

(30)

B C

1* 2 0 !

C

D D

' / !

B <

C

B <

C

D

- 8 - =

' !

B C

& * * C

B < C

B C

B < *

C

B ' C

B <

C

D D

- 8 - =

' !

B 1 2 !

*

! C

( .

& C

1 0 0 0 0

, 0 2

D 0

(31)

0 0

* , .

B *

< C

* *

! ' C

- 8 - =

* , .

$ !

C

! 0' .

$ 0

C B

* . C

B 0

< C

B C

B *

C

D

D D

D

D D

- 8 - =

! 0' .

$ ! , C

$ C

D D

D D '% ')&*#%

" . !

(

& * ! ! 6

# (

(32)

16 ^{The 2}^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Science '" % )(! ( ( $

( ( ( '(*

8( " A %) " "- F ! F =GG= E ! (

( =1>2(

=( # % =GG: " - ! & , 4

B % C( ( :H1 H2(

>30H:(

>( F $" & I( $ =GG: 7 & 4 "

% * % , - (

(

(33)

Ayuni Nazihah Awaludin et al.

! " #

$ % & ! ' $

# ! ' !

( ) $ * !+

! ' #

! ' ! $ ,

- & % . / &

- ! $ & 01

- $ & ( & # #

& !

' $

- & $ 211

$ 314 # # #

" # $ ,! 564 $

714 # # !

$ 814 !

! $ + # !

$ ( & #

# $ ! '

# $ #

$

!

! " #

$ , "

!

$ ( & !

$⁹ % & ! '

$ # ! '

! ( )

$

* !+ :

9$ ! ' $

0$ # ! ' ! $

(34)

Pharmacists in the eye of...

18 ^{The 2}^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences

! " #$

- & % . / &

- ! $

& # # & !

$ & &

$

& 01 - $

& ( & # # & !

'

$ - &

$

, & & ; ( # ; ; <; ;; 95$1

# = >$ & ? $

!% % % %% %

211 $ 824 < @9A1> &

894 < @932> & # $ ,! &

01 26 # <68$54> & 80$54 $

( & # #

$ ! ! & ( & #

! & # $⁰

= 514 &

& # #

# $²

& & ^{9 0 2} !

& ' ! # $

* & ! $ = &

& & $

* ! # ? ?

%

! ' # $

! & $

# $

! #! !

B & ( ( * !$ , % .

/ # $

(35)

Ayuni Nazihah Awaludin et al.

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences 19

!&! ! !%

? ( $,$ .$/$ $/$ C ? D$ B # $B$ 0191 E =

% ; : C ! #

0191$

B ! .$ ; ;$F$ F$ 0191

# # G $

, 7 35)A2$

= /$ D$ / $ $ $ 0119 , # !

" # : , 93 627 628$

(36)

Azza Faturrohmah et al.

20 _{The 2}^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences !

!

" !

" # $

%

& '

!

% " ()

% * +,-

. !

! ! %

/ 0) ),1 !

% / 0) ),1 * %

% / 0) ),1 "

! !

" 2 3

4

"

% ! &

% !

!

5 .

%

! /6 78891

"

(37)

Performance of community...

! !

/ # :)),1 " !

" ! !

! $ '

# /; 78(,< = 5 788+< = . 788>1 "

$

? ' ! . ! . !

!

" # $

%

! " #$

& '

! " !

" ! !

,98 ' ! @@

A) >:< BA) ),< A) 7 !

/C ! 788@1 %

5

= D :))+

% &'

"

$ " '

! . ! . ! ! "

! %

! . !

" !

@& C . & 7 / 1 @ / ! 1

5

= D " ! .

/ :))81 E

! ' ! @&

C . & 7 / $ 1 @ / $ 1

( '

!

77 , C ! '

(38)

22 _{The 2}^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences

) " ) ) )) )

E ! . !

! ! E >)) . 7)-

! . F ! 8@ !

() ! ' / A

(: +@1

" 7 " /G 1

!

+7 99G7) (8 ()- ! ! % $

! /G 1 ! 7+ 87G7) )7 E $

! /G 1 ! . ! 77 (,G8 8@

! >@ ,- #

* +,- . !

/" :1

"

! !

@9- ((- %

C .

! ?D* /? D

* ' 1 /:)):1 ! ! ,)-

! ,)- . ?

.

! ' /6 78891

$

/ 788@<

?D* :)):1

E ! %

" > !

&

$

! ! !

/ 0) ),1 "

$ " + & '

! . ! . ! !

E !

! % / 0) ),1 =

/ *H 1 ! '

! %

/ 0) ),1

% / 0) ),1

(39)

" ! !

!

I ! !

! .

/J :))(1 &

$ "

% ' .

$ % D

! ! /J '

:))+1 " ! 4

#

! / :))@1 5

. %

/?D* 788+1

" )

"

! !

" 2 3

" )

! & !

! % !

!

'

*" # E

#

)

# :)), 5 % =

K 6 , 5

5 < =

5 :))@ L ; C 4 " . E D

H 7+478> 4

4MM . M M -:) -:) ! .M D5C+@:N

-:) .

# :))8 * '

5 98

5 :))8 >&( " .

(40)

788@ F 4

4MM!!! M!!!M M N O A:97P N A

; 6 C 6 6 = 78(, * ' L

4 L

= D :))+ 7):@M= . M QM RM:))+

5

6 = D 7889 5 5 5 = = K

5 C >>8&>,)

C ! D ? Q 6 C! Q 788@ ' D

; # =

= 5 E 5 6 5 . E 788+ 5 " =

6 @8 /+1 4+8>&,),

= . = 788> ? . ; 4 L . M5

5

? D * ' 788+ " E " 5

= ; 4

4MM ! M M M! ' >: M! ' >:

? D * ' :)): E = 4 5 5

?D* = ; 4

4MM ! M M M >)77 M >)77

J ? :))( H C 4 E

:(/7:147+>@&7++: 4

4MM!!! M M M MJ 55 7)&)@

J ' :))+ C . D & 6

D & :))+< 974:,9:&@+ 4

4MM!!! . M N M= Q M= Q M M N

N7: )+

(41)

&' +, - . ' . - . ( ( / (. ( ( '' (/ ( ( (/

) 0

0 - . ( ( 123

! / "

(. (

4 ; ! ,@ /@71 :> /:81

- ; ,9 /@)1 :+ />)1

- ; +@ /,81 >> /+71

( '' (/

- ; ! +, /,91 >, /++1

- ; ! >) />(1 ,) /9:1

( (/

- . ! 78 /:+1 97 /@91

- = ! 7) /7:1 @) /((1

0 '' ++ /,,1 >9 /+,1

&' 5, / 6 ( - . ( ' . ) 0 6 ( (

1(7893

% '

/ 1 G +7 99 G 7) (8

-? ()

-= :)

G 7+ 87 G 7) )7

! . G 77 (, G 8 8@

? . -

9: ,)

S >@ ,)

-

= ! >: ,)

= 9@ ,)

? . ! -

* @ ,)

" 8( @,

5 . 7))

G , ,, G + +(

! . ! . G :@ ,9 G :: 7,

G ( )> G ( 78

G 7, (@ G 7> >9

T= $ ' / 1

T A

(42)

&' :, ( . ( 0 ' . / (. ( ( '' (/

( ( (/ 6 . ( . 6

( 0 ' ( ; )

= 9 )+G) 8>+ ) +(,

" , :(G7 ,,7 ) )+>

C , ((G7 )(+ ) ))7

K$ , 99G) 8,+ ) >(7

&' <, ( . / ( ( ' . / (. (

( '' (/ ( ( (/ 6 . ( . 6

/ ( ( ' ( ; )

? . , ,>G7 7>9 ) @>8

? . 9 ):G) ((7 ) +:8

E ! , 9)G7 7@9 ) ))@

C ! 9 >7G) (), ) 8@(

Table 5. Result of F-test (simultan regression) for individual and organizational factors to drug information, counselling, and monitoring performance

% 1&3

= =

7 E +> @++ ( , +9( + )+: ))7/ 1

E 89 ),9 @7 7 >,>

" 7>8 ()) @8

4 /5 1 C ! " ? . K$ ? . =

E ! C

H 4

(43)

! "

# $%&%'

(

! ) * *

* * ! "

! " + ,

! -

. *

,

! " /% , *

! 0 1$!23 (

!

, 4 5%!%26!

, 4 5%!%26! "

! ,

! !

"

! # '

! 7

! "

# $%&%'

(

! ) * *

* * ! "

(44)

Community pharmacists’ performance...

4 ) $%%8 6!

( (

49 0 &::86! (

4; &::<6!

=

4 + $%%26! " !

"

* ! .

+ 4> ! &:/2? ) @ ! &::8? ) ( &::A6! "

! 9 . ( (

!

" + ,

!

!" # $ %&

- . *

! "

2<: ! . 11

B%!A$? CB%!%2? B%!&

* 4D ! &::16! ,

@

) $%%8!

' ()

"

! " .

( ( ! "

,

!

(

! "

1- D ( - & 4 6

1 4 6!

@ ) ! "

(45)

( 4 ! $%%:6!

E .

1- D ( - & 4 6

1 4 6!

* ) !

*

&&!2! D .

!

" $

E ( *

! E A%% ( &%3

( ! F :1

* /% * . 4 B

/$!816!

" & ! " 4G 6

8&!<<G&%!/: /%3 ! ,

4G 6 &8!:&G&%!%& ! E

4G 6 ( &&!/2G:!:1

! A1!23 +

! E

1&!A%3 /A!/%3 !

" $

!

2%3! 1$!23 (

! " ,

! "

(

- - 4 ! !

6 4

H- I 6 ! " (

J .

49 0 &::A6!

E ,

! " A -

!

4 5%!%26! "

! " 8 - .

( (

(46)

! = .

, 4 K%!%26!

4 5%!%26 4" 26!

) 4 =0H 6

,

4 5%!%26 . 4 K%!%26 4" <

16! .

, 4 5%!%26!

"

! L

(

4M $%%/6! - *

! "

, . (

, !

4M .

$%%86! " * 7

+

4 ! $%%16! @

( ,

49 0 &::86!

$

"

! ,

!

! "

! # '

*

, !

$ !

- ,

!

* ! .

! +$" %"!"

! ! ! E !

(47)

! + ! !

" , " "

.. ! ! )! ! ! J 7 .. . %8N !

" " " "

+ ! $%%2 @ , )

J ; ! 2 @

@ ? )

@! ! $%%1 O > D 7 " ( E *

H !&87&:A! 7

7II !( ! ! I * I 3$% 3$% (I @D81$P

3$% ( !

! + ! $%%: 0 .

@ ! <:

@ $%%: A-/! " ( !

> ;!D! ;! ;!)! &:/2 0 . O !

7 O

) $%%8 = !

) $%%8 = &%$1I) ( I QI RI$%%8!

@ !

; )! ! &::< @ @ @ !)! )!J!

@ D AA:-A2%

D ! !9! Q ;! D !Q! &::1 .

! > + )

) @ E! ! @ ;! ! @ ( E! ! &::8 @ " )

! ; ! 1: 486 78:A-2%2

) ( !)! &::A 9 (! > 7 O ( I@

@

9 0 . &::A " E " @ E

9 0 ) " ( ; A& S A &::A! 7

7II ! ! I I I $::2 I $::2 !

9 0 . &::8 " E " @

) ! > ! 7

7II ! ! I I I . A$ I . A$ !

M 9! ! $%%/ H D 7 E !

$/4&$67&8A1-&88$! 7

7II ! ! I I I IM @@ &%-%1 !

M . ! ! ! $%%8! D ( - ! ;

- ! $%%8? <&7$2<$-18! 7

7II ! ( ! I P I) Q ! I) Q I I P

P&$!%8!

(48)

() -. / 0 * , 1 * ) 1 2 0 * * 3*4567

' )

4 6 G 8&!<< G &%!/:

39 /%

3) $%

= ! G &8!:& G &%!%&

= ! ( G &&!/2 G :!:1

9 ( 3

= <$!2%

T A1!2%

3

) A$!2%

) <1!2%

9 ( 3

0 1!2%

" :/!12

@ ( &%%

= G 2!22 G 8!8/

= ( ( G $1!2< G $$!&2

= G /!%A G /!&:

= G &2!/1 G &A!A<

9 3

T 1&!A%

= $2!%%

9 3

T /A!/%

= &$!2%

U) . 4

6!

U= ! B

() 8. , 1 ) 1 , 1 * 1 * , * # ) , *

* " * 2

2 , 1 * * 397

# / $

: $A 4$:6 21 41&6

- $1 4A86 2A 4<<6

- J A: 48:6 8& 42&6

- $$ 4$/6 2/ 41$6

- > $ 4A6 1/ 4:16

2 )) $$ 4$1!26 2/ 41$!26

(49)

(50)

(51)

Chin Ken Lee et al.

EXPLORING RELATIONSHIP BETWEEN PUBLIC DEMOGRAPHIC CHARACTERISTICS AND THEIR PERCEPTION ON PHARMACIST

AS HEALTHCARE PROVIDER

! "

# $ " "

! % " !

" #

% " % !

# & ' " ( )

* " ' % #

" +, ' # " $

" ! ! " %

-

# ' " #

.,, # % $ " !

,#/00 " ,#1..# !

% 2 3,#,+.4#

" " ! ! 5

" 2 3,#,.64# "

. ,,, ! %

2 3 ,#,,74 $ 2 3 ,#,+84

2 3 ,#,7+4

! % ! ! 2 3 ,#,,74 "

7 ,,, 7 1,,# "

6, ! ! % "

2 9,#,64# % ! : ! %

#

! %

!

$ " !

#⁷ " $ " " # !

" #

$ " " !

" # ;5 ! % "

% !

% #

(52)

Exploring relationship between...

<%= >

7# % " % !

#

+# %

% #

"# $ %&

' " ( ) * "

' % #

" ! ! " %

# " "

#

" +, ' #

" $ " ! ! " %

-

# ' "

#

& " " ? $ ! ? ? 2? ?? 7@#,

! A 4# & " " B ) $ B ?

# ! " 9,#,6#

# ! !

.,, #

! " ! !

! ! ! "

% " " $ #

0.C 2 371,4 07C 2 37/.4 ! #

60#@C +, .6 ! " 0+#@C

#

% $ " ! ,#/00 " ,#1..

B !

! ' 28 AD 7 3,#,+@4

% 28 AD 7 3,#,+.4 #

" " ! ! 5

28 AD 7 3,#,.64 " # ! "

: - % 28 AD 7 3,#,,74 "

#

(53)

Chin Ken Lee et al.

" . ,,, !

5 ! 2 3 ,#,,04 %

2 3 ,#,,74 $ 2 3 ,#,+84

2 3 ,#,7+4

! % ! ! 2 3 ,#,,74 "

7 ,,, 7 1,,#

% " !

6, ! ! % " "

2 9,#,64

!

% ! : ! %

#

% % " ! % %

! " #

# %#"#

B " $ $ < %# & ( )

* ! #

#'# # #

: $ #&# )#*# #*# E : F# B ! #B# +,7, G A

( ? > E % !

+,7,#

B % )# ? ?#;# ;# +,7,

! ! D #

& 8 /@H1.#

A *# F# * # # # +,,7 & ! %

5 ! > & 7/ 6.8 6.0#

(54)

Anila Impian et al.

38

_{The 2}^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences

! "# $% ! !

&&% !

'

& ( ) *+ ) , - .

/011 $"0 !

! - 2

3 4

$$1 ! ! "5 $%

! ! 4 *#& &%.

!

6$ $% &1 1%

*"/ /%. !

7 0 $% -

' ! ! - 66 /% "2%

' ! / &% ! 8

*+9 . +

: ! "

3

;

! ! - -

< ! !

' *) ! /011.

=

4

! "#% !

! *+ - /002.

&&% ! *

(55)

How do indonesian community...

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences

39

/00#. '

#$ ! % &

3 ! =

3 ! & ( ) *+

) , - . /011 3 !

$"0

! ! - 2

3 ! ! !

' ! - '

3

! !

$ % ! ! "

!

8 !

! '

3 !

! -

$"0 ! - $$1

! ! ! 2/% = !

! 3 1

3 1 = 3 >

*?@$$1.

*%.

A :

/& $

#6 # :

//B$2 60B&2 C&2

#$ / // &

6 $

! :

? B

$1 6

"5 $

?

(56)

Anila Impian et al.

40

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences :

9 3!

3

#& &

1# # 6 / 5

: 9 +

?

&0 2 6$ 2 6 "

0 "

7 - *

! -.:

D10 10B/0 /1B$0 C$0

1" /

$/ $

$1 6 /0 1

7 - '

* .:

D&

&B10 11B1&

C1&

65 15 /0 16

#6 #%% ! *//B$2 .

! ! #$ /% ! "5 $% !

! ! ! !

* . 8

*#& &%.

! 6 "% !

3 65% & '

! -

3 !

- '

'

3 / !

3 / 3

(57)

How do indonesian community...

41

*?@$$1.

*%.

:

= (

>

9

60 5 /6 / /2 # 6 &

0 5

3 :

+ 9

&1 1

$&

& 6 5 &

>

: E

9

//

"/ / 11 2 1 &

F - !

:

-

(' +

, >

E

* ! G

G

G .

2& 1G$G1 &

G0 55 #G" #G6

"G0

&" 6G1" &G /6 #G/ 6 5"G# "G& 5

G0 $

"1G1/ /G/1 2G6

"# 6G1$ 6G 1# #G0 "

&$ 6G16 $G /2 "G/ 6 66 /G16 $G

$6 /G#

56 &G#G" $

(58)

Anila Impian et al.

42

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences G0 $

(

: H

?

"$ 6

$& 6

>

:

(' 9

*?@/10.

15 /

&

$/

61 6

$ 6 0 :

(

( $

( "

9 9

11 2 /5 # 1# 1

$"

" $

< :

3 ('

* G .

2/ 1G# 2

$/G"5

$2 $G"0 #

' :

>

+ !

9

* G .

1" &G5$ &

"2G$1

" #G2$ $ / &G2# &

& $G26 # 8

! :

+ +

* G .

50 /G12 5 5" "G1$ 6 5/ 2G1# 1 5/ "G1# 6

"1 "G$5 6

(59)

How do indonesian community...

43

7 !

! ! 60 5% 3 4 &1 1%

*"/ /%.

! "/ /%

- '

! ! ! - !

3 "0% ;

7 ! - -

= - !

- !

= ' 0 $%

-

"$ 6% !

! ' *61 6%.

! - -

!

;

3 4 *$"%.

3

! -

! ! - 3

!

' *"2%. ! " #% !

/ &% ! !

+ !

! - * .

3 !

! *A

> /002. 3 I

! "0%

" "%

+

! '

! +9

3

(60)

Anila Impian et al.

44

" '%$! $#$

• - A 8 ( > 7

, -

• - = *= .

• -

$($ $ "$

/00#

!

" # $ % $

& 3 + : 4 *A

+ .

A > /002 ' ( )*

8 /010 ' + " , ' -

$ ( 3 > :

(

+ /006 J= A : (

J . / *0: /$6B/61

+ - 8 /002 J 9

- > - *3

! . J $

& ) - : - - *

.

+I + ( + F I I - 8 - /00# J

: J

1 2 . $ / *0 ( 3 : /0$B/02

(61)

Ekarina R. Himawati et al.

!

" ! "

# " " "

!

$%

& " !

" !

''( ) * $%

! + ,- $.

! "

/ 0% %. ! " 1 / 2% %. " / 23 3.

" 4 / 5 6. " " /

0 0. " " ! '

,, ,. ! " /

22 2. ! " 1 / 32 %. " 4 / 6 7. "

" / , ,. " " !

! 8 ! "

!

!"# $%&'#!$"

1 9 "

"

) " !

!

" " " :

; <

! "

" # # !

!

! "

(62)

History taking profile on...

9 " 9

&! 4 "

! " #

4 ! " 4 ! "

= 4 "

> 4 1

" / 4

! " /

4 / 4

4

=# &)= (+ ''( ) &? +'*

&?@ =*A+@= B ! # 3%%$

B "

# " = C )

) " D B

" ? ) ( 3%%% "

= C 3-, 2 %%% " 2 ,

! 3%%5

"

! ?

) A 3%%- B

"

! & " "

"

4 !

" "

+ " ! # "

!

( # $%$ $)*

+

": 6,%

& " = C " E ) 3%22 *

" #

!

& "

? " "

"

(63)

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences 47 , +

" " !

''( ) " 2

-

& 6 ! " E )

3%22 !

"

! " !

''( ) +

!

+ . +

?

! >

• 0

• " " "

"

• + F " "

1 "

•

• 1 # " !

"

+ .

?

! >

• 7%

• " " "

"

• + F " "

1 "

•

• 1 # " !

"

' +

A ! "

A ! " "

# 2 " 2 ( !

(64)

% ' + (

& >

2 @ # "

3 @ " !

, ! # "

! " ! "

0 A ! " G

& # "% %! '& !$"

" = A

@ ? @ A & "

27,G *=AG8 )G3%22 B ! ) 9 3%22

"

$7 "

" " H

I 2 ! I 2

I 2 I 0

" !

?

!

Components The information being gathered/asked

W Who is the patient?

W What are the symptoms?

H How long have the symptoms been present?

A Action already taken; what medicines have been tried?

M Medication being taken for other problems?

(65)

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences 49 ,

" 3 2 " " ! "

! "

" 3 ( ! " ! "

History taking components being asked:

Diarrhea in Child

Diarrhea in Elderly

N (%) N (%)

Who is the patient 35 38,9 30 33,3

How old is the patient 36 40,0 10 11,1

Symptoms

Frequency of stools 11 12,2 21 23,3

Abdominal pain 2 2,2 0 0,0

Abdominal bloating/

nausea/vomiting

0 0,0

1 1,1

Stool consistency 9 10,0 8 8,9

Other symptoms (fever) 1 1,1 0 0,0

How long have the symptoms been present

5 5,6

6 6,7

Action already taken 6 6,7 3 3,3

Other medication being taken 0 0,0 3 3,3

2 ( ! " ! "

/

+ $% ,5 ,- $.

" 4

,% ,, ,. ! 4

? "

(66)

"

? ! "

" 1

* 9 " "

" "

D 2$$-

# 0% %. ! "

2% 22 2. ! 4

?

" ?

2 ! "

? " " H

"

! @ " #

# #

=#

" * 3%2%

=# " F

/

" "

" 9 "

"

4 "

! * "

! " / "

! "

4 " ! " "

+

H " ! " !

"

4

" 3 2 $% !

"

4 ! " 22 23 3. $

(67)

- $. '

! " 22 23 3. 32 33 ,.

4 B

9

* 3%2% 8 5. ! " "

"

* ! " "

! 4 *

3%2%

, - 0

5 5 6. ! "

6 6 7. ! "

) " 9 "

" "

2 1 3 , ,

) 3%%3

+

" "

!

6 6 7. ! " " !

, , ,. ! 4

? " " !

" , , ,.

"

$ + 0 ,

" 3 2 ! "

" ! , , ,.

! " "

! " + A " "

) 9 8 # " "

" * 3%2%

'$"' & !$"

! 8 ! "

"'

B ! # 3%%$

) > B ! "

(68)

D = C 2$$- @ & ' C @ @ ) =

3 A 8 = " 8 *

J ! & &

) 3%%$ ) K

C K 36- 3$ C 3%%$ $209$27

) B A A C A = 3%%- A ? " B

& A ) ' B L & 8 ) ) D

C ) @ C A C *

J !> ) L 9( A ? ,%79,32

* 3%2% 3 8 >

2%%922%

! C : @ 3%%% !

>GG ! : G" 9 # 3 " 3%2%

' ( + H 3%%6 " #

! L > '(+

' ( + H 3%%6" $

$ L > '(+ 25932

(69)

Ida Ayu Alit Widhiartini et al.

! " # $

! !

% & #

! # ' % (

! ! ! # !

) * % ( # *

% *

! ! ! )

# % ( ) "

! +,-% &

# +,- . % (

/ 012 3 #

# # +,- 445 # !

!6 % ( * ! ! #

% ( ! #

! " !

/ 3 /

3 /# #3 %

( # % ( # # 4

% 7 2 /05% 83

) * 9

/0 %083 / 5% 83 9 #

: # : / %583 /283

9 / %283 %

; 9 ( # * '

! ! * !

% ( ! !

! ! %

9 * ! / * 3

!"#$ !

< ! ! 7 % &

< =) / <= 3

(70)

Identification of drug related...

>>>1 444 >1 8% ( # 05120

! >551 >> ^{/ 3}%

( 7 # !

44:% 7 # 7 # 48%

7 $ %

#

! %

! " # $

! !

% & #

! # '

% ( ! ! ! #

! ) * %

< ^{/ 3} !

' " % (

#

% (

# !

# % ( #

* % *

! ! ! )

# %

!%& ' ( ) "

! +,- ! 9

- ₇ _%

- ₇ _!

%

( )

! * #

! #

! ! %

$

% ( $

!

! # #

% <

! %

* +!",

& # +,-

. % ( #

#

! % ( : %

(71)

( # ' # #

/ # # # # 3 $ !

445 # ) ! % (

* ! / 3

# ' % ( #

! ! % ( ! # ! "

! /

3 / 3 /#

#3 % (

# %

*,#- , " " ,$#,, !

( # 4 # # #

/ ( ! 3% #

! # # # % ( 010

# ! 01

0012 % ( ? @ #

# # 0 $ #

! % 7 #

# # ! !

! $ ! % ( ! $

! # # ! ^{/ 3}% ( # ! $ %

( ! % & !

& / 3 ! /83

01

01 4 4

01 010

0 0012 :

( !

. " / 0 ' %

' ;;.

" /0583 ! # ! &;=7 /

3 / : 283 &*. ) ! &*. /583

/ ( ! 3% & A ; @77 # !

!

! % & !

! ! $ &;=7 ^{/ 3}%

( ! # ! ! $ #

! A ; @77

! # % #

/ 3 !

% # ! ! $ / 3

(72)

% ( # # # !

! # B % C 6

#

# ^{0 2}% ( $

! !

%

# ! /

! 3 &7 ! !

% ( ! $

# # # %

( ! % * # & ! <

; +,- 445

D &

<

D !

/83

&;= 7 ! ; 0

* %2

&*. E 5 :%

;;. & 2 05

. . $ . 4%>

4%>

0 4%>

4%>

2 )

!

7 ! F<;( %2

; F<;( %5

F FG

4%>

: !

&

1 : 2%

" / 0 % 1

( # 2 4 / 05 8

3 $ * # # $

/:3 $

% *

! # * % )

0> * / 83 # / 83 * *

! %

7 # ! * $ ' #

# ) * % . ' #

* ( ! % ( / ! 0 3 #

) * / ! 2 5 : 2 3 # ) #

* # # ) * % ( ! * #

$ ' ! ! % ( !

(73)

! !

) * %

( ! % 7 * <

; ( ! D / !

3

7

0 & <

& / F F F 3

* 0 : 5 0

:

& &

& F &

& < &. H

; I I

G& / F F F F F F F5F F F F 3

=

C 2 > : 0 2 I(

<; ) !

( B / F F F F F F 3

E # 0 5 2 4 2 ! ( B G&

; / F F F F F F 3

< > & / F F 3

2 ; 1 ; 1

G& D ! I

; 1& / F:3

9 ) * ! )

* % 2 # %

( % (

! I #

# $ $ % & A ; @77 !

! 4I54 < % (

! $

% # &;=7 &*. # 0

# &;=7 &*. # ! % ! !

! % # !

# % C ! ! ! $

% . ! $ ! !

) ^/:3%

( # # !

% ( # ! I . )

! & < & ! "

%

(74)

# # ! # ) # $

4 ! ) ! 0

< 0 # $

B 0 G 4 # # ! %

* ! ! ! B %

# !

/: >3% ( # # #

0 ) ! %

& # ! ! 24 G B 0 G 4

0 G 0 G 4 G G&

! %0I 044 ) ! G # #

! # # 7G 7 ^{/ 43}% &

# ! # !

% $ "

% . !

"

%

# ! 4

# 7G 7 / 4 G 3% 7 $

) )

/5 >3%

C # ) &;= !

# G& ! % !

G& % (

$ # ! B

G& ^/> ³%

& *

# # !

# % & # 6 ' !

# ! #

# # ' %

! ' !

% $ !

'

' % ( * !

!

%

(75)

$! $-#, !

7 * ! (

; +,- ;;. /0583 "

! # ! &;=7 / 3 / : 283 &*.

E ) ! &*. /583 %

C * # 2 4 /05% 83

9

/0 083 / 5% 83 9

# : # : / %583 />83

9 / %283 % ( !

%

$

! &;=7 ; & /D ! 3

& & & % ( !

! # !

! ' %

* * * $*

& 44>% < $ * $ $ ? $ % & ! 9

9II $$ $% I##I ) % J K L L K 2 G 94: A

4 4

< ; E % >>4% G ! % & A

< % M :90 1 %

? @ &!! &$ 440% < @ 7 9 * !! ;

. : 9 = %0 510 >%

D B ? 445% & 7 9 D B ?% ;

* ; = % %:421: >%

; *% A% >>5% ; ( D # <

;

A ; >> %

% C < @ 09 4 1 40%

D AM ; ! A% 44 % = ; <

* % A & & /23 ! 9 ###%

% I # I >> : A 44 %

B 44 % ( B 9 ! ! & % =

< A G G 1G 0%

$ 7 < 44 % 7 0 D . ; !

& 442% ; $ $ < A $ 9 $ .

?G ?E $ 6 . ? & ?

? %

* % @ $ ?? . ) < 44>% ; ! % # 9

###% $ % % >% %

%A % 440% % 9 (

D # N < ;

(76)

J L Quah et al.

! " #

$ %" #$& ' % ( & )**+

' ' ' ! ,

" #$ ' '

! - ' - .

" #$ - - ! # - - ' '

! ( ,/0 " #$ ' 1)

' 2 )**3 )**4 )**5 )**6 )*1*! # - '

%7 $& ' 5 )**+!

)**+ )**3 )**4 )**5 )**6 )*1* ' 54 1)5 15+

)88 )4* )58 - ! 3 '

- ' 9 :

%)**+;+4!*< )**3;38!*< )**4;3)!)< )**5;3+!8< )**6;4*!+< )*1*;36!*<&!

' = ,/0 - %

,/0>1!+ ,/0?8!+&! ' - =

- %)**+;14!4 )**3;15!6 )**4;13!4 )**5;13!8 )**6;1+!4

)*1*;14!1&! , .

" #$ - ! / - " #$

- - - !

@ '

!"# $%& #!$"

" ' - 16A* '

! , ' - ! ' -

' - 16+* !¹B-

'

' = !⁾ '

C %,/0&! D . '

- -

- - ,/0 )!*=A!*! D ' .

' -

(77)

Five year evaluation of...

- - =-

,/0 )!+=A!+!^A

-

!⁸, ,/0 - '

- ! ' ' '

'

= = -

!^{) 8 + 3 4} - .

' ' : : 1 %E (0$1&

' = - - !⁵ -

' . =. ' -

! F : C C '

C ' !^{) 3 6}

'

1*! , ' -

= %#$& G

,/0 -

= - !^{) 8 6 1*}

= - ' -

' ,/0 '

!^{) 6} = '

!^{) 4}

" # $ %" #$& '

% ( & )**+ '

' ' ! , " #$ '

' ! , ' C " #$

- - - ' -

%7 $& - ,/0 !

- ' - .

" #$ - - !

'# $%$ $ (

' ' ' ' ' '=

( % ( & " $ % ( &

! H )**+ (

' ! D %#$&

' I 9 %7 $&! , )**+ -

' ' '

" #$! ,/0 ' - -

= -

C %#$J 4***2 , J , &! D 7 $ " #$

,/0 '

!

(78)

J L Quah et al.

% ( ) * + % ** , -

- ' - - ' '

! - ' - '

" #$ - 2 )**3 )**4 )**5 )**6 )*1*!

' - ' 7 $

5= %D 1 )**+ A* )**+&!

' - = - !

' ,/0 ' !

" ' ' .

,/0 '

!

.* * ,

' ' 15 !

- ' ,/0 - - ! ,/0 - '

' !

- ,/0 ' : ' !

- C ' % 8 ' &!

! /

" #$ '

!

! '

' = -

- '

= = = = !

G

- ' C

- ! , ' ' - !

'= -

11 1) 9 - ,/0! '

1*< ' ' . ! '

' - - - !

$ ,

' ' K *!)

,/0 % : &! K *!)

' ' . !^{8 3}

$ ' ' ! % &

' ,/0 - '

= ! ' 0

!^1A '

,/0 ,/0 !^1A

(79)

The 2^ndInternational Conference on Pharmacy and Advanced Pharmaceutical Sciences 63 ,/0 -

%,/0 > 1!+ ,/0 ? 8!+& ' ' - !

, * *

' L⁾ ! 9

= ' ! # ' ' = =

- M *!*+ ' ! '

% & E 14 N % ,/$! $ ,J 7 #&

E %E 9 $ /O 7 #& ' !

' & # "% %! & !$"

1 C !

)**+ )**3 )**4 )**5 )**6 )*1* ' 54

1)5 15+ )88 )4* )58 - ! 3 '

- ' 9 :

%)**+ ; +4!*< )**3 ; 38!*< )**4 ; 3)!)< )**5 ; 3+!8< )**6 ; 4*!+< )*1* ;

36!*<&! ' = ,/0 - %

,/0>1!+ ,/0?8!+&! ' - =

- %)**+;14!4 )**3;15!6 )**4;13!4 )**5;13!8 )**6;1+!4

)*1*;14!1&! 0 ) !

! = -

- - ' 8!8< )5< '

7 $ ' - !) 8 3 18 1+

' -

' 9 : ! J ⁾

= %7 $&

!

,/0 : !⁾

, - " #$ ' '

,/0 ! = = - ' !

18 13 - - -

' ' ' -

,/0 - !

,/0 . ,/0 '

15!6 %)**3& 1+!4 %)**6& 14!1 )*1*! - ' -

-

!⁾ ' -

- . '

' ' ' ! - '

'

! )*1* # (=

" % ' & ( ! '

' ' 9 ,/0!

(80)

J L Quah et al.

- '

: P' ' - ! (- -

' '

!⁾,

' " #$ '= !

-

' - -

!⁴ -

-

,/0 ! " #$ : -

- - !

- = '

- !⁴

# - " #$

8 1* 1+ 14 - - ' ,/0

= ' - ' ,/0=

C !

' - ' -

- ! D ' :

' 9 !

D '= ' - ! ,

' '= .

!

- !

- - -

- - ! / -

' :

!⁶

' ' %

- & ' ' ' '

!³

( ' - '

' :

! # - - -

: !

'

" #$ - ! - '

!

$" & !$"

, . " #$

- ! / - " #$

- - - !

(81)

"$ '% ' '"#

(

( ' ! " '

! '-' '" '

D H ! @

Q @ R ! )**+26*%A&!

' $J H / J ! F

= C

' ! ! )**52)5@)*=3!

H # 0 H ! H /

D +1! 7 @ 0 ! )**3 !

$ D" " 0 J " $ O $ O R ! $

' ' - S -

C ! H R $ ! )**32 3)%+&@3*1=6!

" 0 B H ' D R! , - ( C

, - - @ # $ B B-

" ! , - - R @ , -

R ! 11%1&!

" R " - R J ' R H B ! $ .

@

C ! $ # R ! )**A2136%8&@)6A=5!

#! B # - ,/0 E 0

$ T U! 7 - 2 )**+!

E J O R 0 R D D " H ! #

- : 1 %E (0$1& - ' '

$ ! ! )**+21+@354=61!

" ' # / B# H R R R R ! (

- = -

! $ R ! )**321A*@1A5+=6!

$ # /# 0 C ! $

' ! R#HD ! )**1218%1&!

! = " $

( ! )**+!

@ ' ! J @ !

)**4!

0 D0 $ $ - DR H B! #

! 166A2A6@)A3=6!

" # 0J CC R! B C

- ! $ B )**+2

1)4%+&@ 1+1+=))!

$ . B # H ,! $ '

! # , 166521+5@1381=4!

# R J # ! # ! $ )**12

116% &@ 168 =)*3 !